HepHIV 2026 Conference

By Ana Balkandjieva

18 February 2026

Testing

From 2 to 3 November

The HepHIV 2026 Conference will take place in Dublin, Ireland from 2 to 3 November 2026.

Since 2007, the EuroTEST Initiative has organized biennial conferences on optimal testing and earlier care, focusing on both hepatitis and HIV.

The conferences bring together civil society, policymakers, health professionals and European public health institutions and provide these stakeholders with the opportunity to learn from each other and to reflect on experiences, achievements and challenges.

The conference format includes a mix of plenary sessions, expert panel and roundtable discussions and moderated parallel sessions.

Visit the HepHIV 2026 Conference website.

Related materials

Development and Optimisation of a Reception Testing Protocol Designed to Eliminate HCV in the UK Prison Population

A study shows that an opt-out HCV test and treat initiative in prison receptions is feasible and can be adapted to the needs of individual prisons as a viable way to achieve HCV micro-elimination. More

16 March 2024Learn Diagnostics

The New South Wales Dried Blood Spot Pilot

Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot More

16 March 2024Learn Diagnostics

Point-of-Care Testing Increases HCV Treatment Uptake in Priority Settings in Australia

Among patients in 3 priority settings, the implementation of hepatitis C virus antibody and RNA point-of-care testing led to higher rates of testing, treatment uptake, and linkage to care. More

20 May 2024Learn Diagnostics

Launch of WHO Operational Guide on Priorities in Planning Person-Centred Hepatitis B and C Testing Services

Webinar, organized by the World Health Organization. More

25 November 2024News Calendar

Priorities in Planning Hepatitis B and C Testing Services: New WHO Operational Guide

The purpose of the guide is to support countries in developing policies that define a strategic mix of hepatitis B and C testing approaches, tailored to their unique situation ensuring an impactful national response to the hepatitis epidemic. More

10 December 2024Learn Diagnostics

Cost-Effectiveness Analysis of US Emergency Department-Based Hepatitis C Screening and Linkage-To-Care Program

A study examined the long-term cost-effectiveness of routine HCV screening and linkage-to-care for high-risk patients in the US emergency department from the payer’s perspective. More

20 March 2025Learn Care

“It’s Not Just Running the Test”: Operator Experiences of Implementing a Decentralised Hepatitis C Point-Of-Care Testing Program in Australia

A study explored operator experiences, including the challenges and enablers, of implementing point-of-care testing as part of a National Point-of-Care Testing Program. More

9 May 2025Learn Diagnostics

Acceptability of Hepatitis C Testing Using Point-Of-Care Testing and Dried Blood Spot Collection Among People at Risk of Hepatitis C Infection

A study evaluated the acceptability of dried blood spot and point-of-care testing among people at risk of HCV infection and examined the circumstances in which such testing is most preferred. More

9 May 2025Learn Diagnostics

Frequent Hepatitis C Testing Among PWID Found to Be Cost-Effective, Study Finds

Study findings underscore the cost-effectiveness of more frequent hepatitis C testing among people who inject drugs, compared to less frequent or no testing at all. More

19 July 2025Learn Diagnostics

US: Biannual Hepatitis C Testing Could Reduce Infections Among PWID

Testing PWID for HCV every 6 months could reduce HCV prevalence by up to 45%, incidence by 37%, and HCV-related deaths by 42% over 10 years. More

11 August 2025Learn Diagnostics